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The significance and extent of Ca2 regulation of the biosynthetic secretory pathway have been difficult to establish, and
our knowledge of regulatory relationships integrating Ca2 with vesicle coats and function is rudimentary. Here, we
investigated potential roles and mechanisms of luminal Ca2 in the early secretory pathway. Specific depletion of luminal
Ca2 in living normal rat kidney cells using cyclopiazonic acid (CPA) resulted in the extreme expansion of vesicular
tubular cluster (VTC) elements. Consistent with this, a suppressive role for vesicle-associated Ca2 in COPII vesicle
homotypic fusion was demonstrated in vitro using Ca2 chelators. The EF-hand–containing protein apoptosis-linked
gene 2 (ALG-2), previously implicated in the stabilization of sec31 at endoplasmic reticulum exit sites, inhibited COPII
vesicle fusion in a Ca2-requiring manner, suggesting that ALG-2 may be a sensor for the effects of vesicular Ca2 on
homotypic fusion. Immunoisolation established that Ca2 chelation inhibits and ALG-2 specifically favors residual
retention of the COPII outer shell protein sec31 on pre-Golgi fusion intermediates. We conclude that vesicle-associated
Ca2, acting through ALG-2, favors the retention of residual coat molecules that seem to suppress membrane fusion. We
propose that in cells, these Ca2-dependent mechanisms temporally regulate COPII vesicle interactions, VTC biogenesis,
cargo sorting, and VTC maturation.
INTRODUCTION
Although Ca2 is a required cofactor in many types of
exocytosis, it has been less clear what role Ca2 plays in the
constitutive membrane fusion reactions constituting the se-
cretory and endocytic pathways. Indications that Ca2 is
required for constitutive trafficking have come from studies
of endoplasmic reticulum (ER)-to-Golgi trafficking (Beckers
and Balch, 1989), intra-Golgi transport (Porat and Elazar,
2000), endosome and lysosome fusion (Colombo et al., 1997;
Peters and Mayer, 1998; Pryor et al., 2000). In most cases,
fusion is inhibited by the fast Ca2 chelator 1,2-bis(2-amino-
phenoxy)ethane-N,N,N,N-tetraacetic acid (BAPTA), but
not by EGTA, a slower chelator of comparable affinity. This
has led to the conclusion that Ca2 must play its required
role during a short pulse (1 ms) of released luminal Ca2
or else a Ca2 gradient localized very near the transport
machinery (Chen et al., 2002; Burgoyne and Clague, 2003;
Hay, 2007). It has also been suggested that constant leakage
of luminal Ca2 from the ER and/or Golgi may create
perpetual Ca2 gradients surrounding these organelles;
steady-state Ca2 gradients around secretory organelles
have been suggested by Ca2 imaging techniques (Wahl et
al., 1992). Basal Ca2 leak from secretory organelles displays
properties indicative of an ion-conducting channel; how-
ever, the most significant proteins responsible remain debat-
able (Camello et al., 2002). However important luminal Ca2
may be at some stages of trafficking, luminal Ca2 does not
seem to play a universal role as a trigger of membrane
fusion, because membrane-permeant chelators added to in-
tact cells revealed a mosaic of Ca2-dependent and Ca2-
independent transport steps (Chen et al., 2002). Little
progress has been made in elucidating mechanisms of Ca2
action in constitutive trafficking, although there are a few
interesting hints. Calmodulin antagonists have implicated
this effector in several constitutive transport steps that re-
quire Ca2 (Burgoyne and Clague, 2003); downstream tar-
gets may include Ca2-dependent protein kinase II, soluble
N-ethylmaleimide-sensitive factor attachment protein recep-
tors (SNAREs), and vesicle tethers (Colombo et al., 1997;
Mills et al., 2001; De Haro et al., 2003). Other Ca2 effectors in
the constitutive secretory pathway include the coat proteins
responsible for transport vesicle formation. Membrane-per-
meant BAPTA destabilizes COPI binding to membranes in
vivo (Ahluwalia et al., 2001). Furthermore, the penta-EF-hand
(PEF) protein apoptosis-linked gene (ALG)-2 is present at ER
exit sites, and, when Ca2 is present, stabilizes association of
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the sec31 COPII subunit at the membrane (Yamasaki et al.,
2006; la Cour et al., 2007; Shibata et al., 2007).
Vesicle coats such as COPII, COPI, and assembly protein
(AP)-clathrin concentrate cargo and deform membranes to
form spherical vesicles with highly sorted membrane and
luminal contents (Barlowe et al., 1994). The traditional view
has held that shortly after vesicle budding, guanosine
triphosphate (GTP) hydrolysis by sar or arf would trigger
coat depolymerization and its quantitative loss from the
membrane (Bonifacino and Glick, 2004). This view was re-
inforced by the presence of GTPase activation protein (GAP)
activities intrinsic to coats, naturally leading to the idea of
concerted coat dissolution after budding. Recently, however,
evidence has accumulated that at least a portion of some
coats remains on vesicles during the docking phase and in
fact assists this function by serving as targeting sites for
tethers. This represents a new information-encoding func-
tion for coats in vesicle transport. For example, the COPII
inner shell subunit sec23 serves as a targeting site for the
tether mBet3 of transport protein particle (TRAPP)I and is
required for successful homotypic COPII vesicle tethering in
mammals and COPII vesicle-Golgi tethering in yeast (Cai et
al., 2007). Immunoisolation of mammalian pre-Golgi inter-
mediates after tethering reactions revealed stably associated
pools of inner and outer shell COPII components, although
the exact stage after TRAPP-mediated tethering at which the
residual coat is shed has not been determined (Cai et al.,
2007).
Much of the machinery for ER-to-Golgi transport has been
identified. In mammalian cells, cargo moves from the ER to
Golgi in pleomorphic vesicular tubular clusters (VTCs) that
travel along microtubules (Presley et al., 1997; Scales et al.,
1997). VTCs are part of a broader network of vesicles and
tubules often referred to as the ER-Golgi intermediate com-
partment (ERGIC) (Saraste and Svensson, 1991). Some VTCs
may be long lived and relatively immobile sorting stations
that give rise to the transient, mobile structures (Ben-Tekaya
et al., 2005). ER-to-Golgi cargo transport must involve at
least two membrane fusions—one fusion to transfer cargo
from COPII vesicles into VTCs in the periphery of the cell—
and a second fusion to transfer cargo from Golgi-centric
VTCs into the cis-Golgi (or alternatively to create the cis-
Golgi de novo). COPII vesicles in vitro contain all compo-
nents necessary for homotypic tethering and fusion to form
nascent VTCs (Xu and Hay, 2004; Bentley et al., 2006). Thus,
homotypic COPII vesicle fusion seems to represent at least
one pre-Golgi membrane fusion contributing to VTC bio-
genesis and anterograde transport. Rab1 seems to represent
a coordinating factor for ER-to-Golgi transport and has sev-
eral effectors (Allan et al., 2000). These include the golgins
p115 (Uso1p in yeast) and GM130, which are required for
ER-to-Golgi transport (Alvarez et al., 2001; Moyer et al.,
2001); p115 is also required for in vitro homotypic COPII
vesicle tethering and fusion (Bentley et al., 2006). The seven-
member TRAPP complex includes subunits mbet3 and sed-
lin, is required for ER-to-Golgi transport, and seems to rep-
resent a tethering factor for COPII vesicles and a guanine
nucleotide exchange factor for rab1 (Sacher et al., 2001; Loh
et al., 2005; Yu et al., 2006). Both the golgin p115 and TRAPP
have been implicated as tethering machinery for COPII
vesicles; their precise functional relationship remains to
be determined. The fusion machinery consists of SNARES
syntaxin 5, membrin, rbet1, and sec22b, which form a well-
characterized quaternary complex that has served as a pro-
totype for intracellular SNARE complexes (Xu et al., 2000;
Joglekar et al., 2003; Xu and Hay, 2004).
This study was designed to investigate the potential role
and molecular mechanism of luminal Ca2 in early steps in
ER-to-Golgi transport. We found that luminal Ca2 dramat-
ically influences VTC size and distribution in cells. Further-
more, we examined the potential role of the EF-hand–con-
taining protein ALG-2 and its coat-stabilizing activity as
effectors of luminal Ca2 to regulate COPII vesicle fusion
and VTC biogenesis.
MATERIALS AND METHODS
Depletion of Luminal Calcium
Ca2-free DMEM (D9802-05B; US Biological, Swampscott, MA) was supple-
mented with 10% fetal bovine serum that had been dialyzed (twice for 2 h) in
a 100-fold excess of Ca2-free phosphate-buffered saline (PBS). Cells to be
depleted of luminal Ca2 were washed twice with Ca2-free DMEM/10%
fetal bovine serum (FBS) containing 10 M cyclopiazonic acid (CPA; C1530,
Sigma-Aldrich, St. Louis, MO), 1 mM EGTA, and 25 mM HEPES, pH 7.2, and
then incubated in that medium for 15 min. This was followed by an incuba-
tion (usually 15 min) in Ca2-free DMEM/10% FBS, no CPA, 0.3 mM EGTA,
and 25 mM HEPES, pH 7.2. Some treatments included 10 g/ml cyclohexi-
mide for a 30-min period before addition of CPA; in these cases, cyclohexi-
mide was also maintained in the medium during the CPA treatment and
subsequent Ca2-free chase. A 30-min cycloheximide pretreatment has been
shown to block ATF6 activation by thapsigargin in HeLa and COS cells (Haze
et al., 1999).
Immunofluorescence
For immunofluorescence, coverslips were dropped directly into wells of room
temperature 4% paraformaldehyde in 0.1 M sodium phosphate, pH 7.0, for 30
min. Samples were then quenched twice for 10 min with 0.1 M glycine in PBS.
Cell permeabilization was then carried out for 15 min at room temperature by
using permeabilization solution (0.4% saponin, 1% bovine serum albumin
[BSA], and 2% normal goat serum in PBS), followed by incubation in primary
antibodies diluted in permeabilization solution for 1 h at room temperature.
After three rigorous washes with permeabilization solution, the coverslips
were incubated with secondary antibodies diluted in the same buffer for 30
min, followed by three more washes. For immunofluorescence of Sec16,
coverslips were washed with PBS and then fixed for 10 min at 20°C in 100%
methanol, and the antibody incubation/wash solution was PBS, pH 7.5, plus
1% BSA. Coverslips were mounted using Vectashield anti-fade solution (Vec-
tor Laboratories, Burlingame, CA) and analyzed using an E800 microscope
(Nikon, Tokyo, Japan) with a 60 plan APO numerical aperture 1.40 objec-
tive. Images were collected using an ORCA 2 digital camera (Hamamatsu,
Bridgewater, NJ) controlled by OpenLab software (Improvision, Coventry,
United Kingdom). Images for quantitation were collected in a consistent
manner with regard to cell morphology, protein labeling intensities, and
exposure. After choosing a fixed exposure time for each color channel that
would accommodate the majority of cells, we avoided any cell whose inten-
sity values in any color exceeded the saturation value of 16383 or fell below
4000 on our 14-bit acquisition system. We also avoided capturing cells lacking
a flat morphology and single, well-defined nuclei surrounded on all sides by
an expanse of cytoplasm. Only cells exhibiting relatively strong and clear
rbet1 labeling were selected. An image stack was collected for each color
channel for each field of cells randomly encountered containing at least one
cell that met the necessary objective criteria for quantification.
Quantification of Images
Separate excitation and emission filter wheels equipped with fluorescein
isothiocyanate (FITC) and cyanine (Cy)3 filter sets were used, and 21 image
planes were captured in 0.2-m increments. Images were deconvolved using
Huygens Essential Widefield software (Scientific Volume Imaging, Hilver-
sum, The Netherlands). For a given field, a single image plane containing
rbet1 labeling in focus in the peripheral cytoplasm was selected, and the
background labeling was removed by defining a dark extracellular area of the
image as zero using the automation tool in OpenLab. An rbet1 object binary
image mask was generated by thresholding rbet1 labeling at 4 times over its
intensity in a peripheral area lacking punctate objects (i.e., the labeling of
rbet1 in the ER). A Golgi mask was then created by thresholding the GM130
labeling at 25% of its maximum intensity. The Golgi mask was subtracted
from the rbet1 object mask using Boolean operations to generate a peripheral
rbet1 object mask; this mask was used to identify and quantify pixels within
peripheral rbet1 objects. Peripheral p24 objects were quantified in the same
manner using a Golgi mask.
Antibodies
Monoclonal anti-rbet1 antibodies were described previously (Hay et al., 1998).
Affinity-purified polyclonal anti-p24, -sec23, and --COP from our laboratory
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were described previously (Bentley et al., 2006). Anti-sec31 was produced in
rabbits against the synthetic peptide KLKEIDRTAMQAWSPAQNHPC and
then affinity purified using a column of the immobilized peptide. Anti-GM130
and -p115 were a kind gift from Dr. Martin Lowe (University of Manchester,
Manchester, United Kingdom). Anti-ALG-2 was a kind gift from Dr. Mas-
ayuki Komada (Tokyo Institute of Technology, Tokyo, Japan). Anti-sec16
antibody (KIAA0310) was acquired from Novus Biologicals (Littleton, CO).
Anti-GPP130 antibody (PRB144C) was purchased from Covance Research
Products (Princeton, NJ). Anti-protein disulfide isomerase (PDI; SPA-890) was
from Assay Designs (Ann Arbor, MI). Anti-IP3R-3 (610312) was purchased
from BD Biosciences Transduction Laboratories (Lexington, KY). Anti-man-
nosidase II antibody (MMS-110R-200) was purchased from Covance Research
Products. Anti-myc monoclonal antibody (mAb) 9E10 was purified from
hybridoma tissue culture supernatant. Secondary antibodies were FITC or
Cy3 conjugated and purchased from Jackson ImmunoResearch Laboratories
(West Grove, PA).
Luminal Ca2 Measurements
Normal rat kidney (NRK) cells (80% confluent) were transiently transfected
with 1.5–2 g of purified plasmid DNA of the respective Ca2 sensor using
TransFast (Promega, Vienna, Austria) as described previously (Trenker et al.,
2007). Cells were used for experiments at 48 h after transfection. YC3.6
(Nagai et al., 2004) and YC2.1 (Miyawaki et al., 1997) were used to monitor the
free Ca2 concentration in the cytosol, and D1ER (Palmer et al., 2004) was
used to monitor free Ca2 within the ER lumen (Malli et al., 2005; Osibow et
al., 2006). The fluorescence resonance energy transfer-based Ca2 sensor
D1ER was excited at 440  21 nm (440AF21; Omega Optical, Brattleboro, VT),
and emission was collected simultaneously at 535 and 480 nm with a single
camera using an optical beam splitter (535 and 480 nm, Dual-View Micro-
Imager; Optical Insights, Visitron Systems, Puchheim, Germany). [Ca2]Cyto
was calculated from the normalized ratio values Ratioin  Fi535/Fi480	F0535/F0480	 using
the following equation: 
Ca2  KD  Ratioin  RatiominRatiomax  Ratioin M (Osibow et al.,
2006). The KD value for YC3.6 was assumed to be 250 nM (Nagai et al., 2004).
For the calculation of [Ca2]ER, the raw D1ER recordings (Ratio F535/F480)
were corrected for bleaching using a calculated individual bleaching-function
(R0) by subtracting R0 from the raw Ratio F535/F480. From this curve the
respective Ratioi, Ratiomin, and Ratiomax values were extracted and [Ca2]ER
was calculated using the equation above. The KD value of D1ER in situ for
calculating [Ca2]ER was assumed to be 220 M according to Rudolf et al.
(2006). Ratiomin and Ratiomax were determined using 1 M ionomycin in 1 mM
EGTA and subsequently in 2 mM Ca2-containing solution, respectively, for
each single measurement (cytosolic Cameleons and D1ER). Statistical data for
Ca2 measurements are presented as mean  SEM. Analysis of variance and
Scheffé’s post hoc F test were used for evaluation of the statistical significance,
with p  0.05 defined as significant.
Cloning, Expression, and Purification of Recombinant
Proteins
A mouse ALG-2 cDNA clone (IMAGE:3156800; MGC:49479) was purchased
from American Type Culture Collection (Manassas, VA). The full-length
coding region was amplified using polymerase chain reaction (PCR) and
specific primers to incorporate XbaI and XhoI restriction sites: 5-CCATA-
TTCTAGACGCTGCCTACTCCTACCGCCC-3 (coding strand) and 5-CCA-
TATCTCGAGTTATACAATGCTGAAGACC-3 (noncoding strand). The am-
plified ALG-2 fragment was subcloned into the XbaI/XhoI cloning sites of the
pGEX-KG expression vector (Guan and Dixon, 1991) to construct the GST-
ALG-2 expression vector. We used QuikChange PCR mutagenesis (Strat-
agene, La Jolla, CA) to introduce E473A and E1143A mutations into the
ALG-2 EF hands 1 and 3, respectively. Using the GST-ALG-2 construct as
template, the following mutagenesis primers were used: E47A, 5-GGAGT-
GATTCAGACAATGCGCTTCAGCAAGCATTATCC-3 (coding strand) and
5-GGATAATGCTTGCTGAAGCGCATTGTCTGAAATCACTCC-3 (noncoding
strand); and E114A, 5-GGATGATTGACAAGAACGCGCTCAAACAAGC-
ACTCTC-3 (coding strand) and 5-GAGAGTGCTTGTTTGAGCGCGTTCTT-
GTCAATCATCC-3 (noncoding strand). All expression constructs were ver-
ified by sequencing of the entire insert. The resulting GST-ALG-2 wild-type
and double mutant expression vectors were transformed into Escherichia coli
NM522 for protein expression.
GST-ALG-2, GST-ALG-2 E47,114A, and glutathione transferase (GST) con-
trol strains were grown in Luria broth at 37°C to an A600 of 0.4–0.6 and
induced with 0.1 mM isopropyl-1-thio--d-galactopyranoside (IPTG) for 2–3
h. After harvesting the cultures, each 3-l culture of bacteria was resuspended
in 60 ml of French Press buffer (50 mM Tris, pH 8.0, 0.1 M NaCl, 1 mM EDTA,
1 mM dithiothreitol [DTT], and protease inhibitors [Complete EDTA-free;
Roche Applied Science, Indianapolis, IN)], disrupted twice with a French
Press and clarified by centrifugation at 20,000  g for 20 min followed by
100,000  g for 1 h. The final supernatants were applied to a 2-ml glutathione-
Sepharose column (GE Healthcare, Little Chalfont, Buckinghamshire, United
Kingdom), equilibrated, and washed extensively with PBS, and then eluted
with 50 mM Tris, pH 8.0, 20 mM glutathione. The eluted protein was then
dialyzed extensively in 25/125 buffer (25 mM HEPES, pH 7.2, and 125 mM
potassium acetate) and stored in single-experiment aliquots at 80°C.
GST-sar1a T39N in a pGEX vector was obtained from Drs. Jinoh Kim and
Randy Schekman (University of California–Berkeley, Berkeley, CA). Three
liters of culture was grown in Luria broth containing 100 g/ml ampicillin at
37°C to an optical density of 0.4–0.6, and then protein expression was
induced by addition of 0.1 mM IPTG for 2 h. Bacterial pellets were resus-
pended in French Press buffer containing 1 mM DTT, 10 M guanosine
diphosphate (GDP), and 5 mM magnesium acetate, and a soluble extract was
prepared as for GST-ALG-2 described above. The final extract was loaded
onto a 2-ml glutathione-Sepharose column, washed with PBS containing 10
M GDP and 5 mM magnesium acetate, and eluted with 50 mM Tris, pH 8.0,
20 mM glutathione, 10 M GDP, and 5 mM magnesium acetate. The purified
GST-sar1a T39N was then digested with thrombin, dialyzed extensively
against 25/125 buffer containing 10 M GDP and 5 mM magnesium acetate,
and stored at 80°C.
Heterotrimerization Fusion Assays
COPII vesicle fusion experiments (see Figures 3, 5, and 6) were carried out as
described previously (Xu and Hay, 2004; Bentley et al., 2006; Cai et al., 2007).
In brief, the vesicular stomatitis virus-glycoprotein (VSV-G)-myc–expressing
NRK cells and pulse-radiolabeled VSV-G*–containing cells were permeabil-
ized by scraping with a rubber policeman and then washed and resuspended
at 170 l/10-cm plate in 50/90 buffer (50 mM HEPES, pH 7.2, and 90 mM
potassium acetate). A first-stage (vesicle release) incubation to produce
enough vesicles for a 24-point fusion assay contained 1.96 ml and consisted of
432 l of water, 67.5 l of 0.1 M magnesium acetate, 135 l of ATP-regener-
ating system, 40.5 l of 1 M HEPES, pH 7.2, 270 l of weak calcium buffer (20
mM HEPES, pH 7.2, 1.8 mM CaCl2, and 5 mM EGTA), 675 l of dialyzed rat
liver cytosol, and 337.5 l of either of the permeabilized cell populations.
After incubation at 32°C for 30 min to allow vesicle release, cells were
removed by centrifugation at 4000  g for 1 min followed by 15,000  g for
1 min. The supernatant, which contains released COPII vesicles, was saved.
For the second-stage fusion incubations, each reaction totaled 200 l and
contained 72.5 l of VSV-G-myc vesicles, 72.5 l of VSV-G* vesicles, and 55 l
of 25/125 buffer or test components dissolved in 25/125 buffer. It was at this
point that proteins such as GST-ALG-2 or test chelators such as BAPTA were
added. After a 20-min preincubation on ice with these test components, the
reactions were incubated at 32°C for 60 min to allow tethering, fusion, and
heterotrimerization between VSV-G-myc and VSV-G* vesicles. For measuring
heterotrimers, the final vesicle suspensions were supplemented with 2%
Triton X-100, incubated with agitation at 4°C for 20 min, and then centrifuged
at 100,000  g for 30 min. The 100,000  g supernatants containing solubilized
VSV-G trimers were then processed for immunoprecipitation by using 5 g of
biotinylated anti-myc antibodies and 5 l (packed) streptavidin-Sepharose
(GE Healthcare). Immunoprecipitates were solubilized in SDS sample buffer,
analyzed by SDS-polyacrylamide gel electrophoresis (PAGE; 8%) and phos-
phorimaging, and coprecipitated VSV-G* was quantified.
For immunoblotting of transport intermediates such as in Figure 4, a similar
setup to that described above was used except that only VSV-G-myc–express-
ing cells were used because radioactivity was inconsequential to this assay.
After scraping and washing as described above, the cells were resuspended in
170 l of 50/90 buffer/10-cm plate. Each immunoisolation condition in-
volved a reaction volume of 600 l and contained 96 l of water, 15 l of 0.1
M magnesium acetate, 30 l of ATP-regenerating system, 9 l of 1 M HEPES,
pH 7.2, 60 l of weak calcium buffer (see above), 150 l of dialyzed rat liver
cytosol, 165 l of 25/125 buffer or test proteins dialyzed in this buffer, and 75
l of VSV-G-myc–expressing or control NRK cells. In certain control reac-
tions, 800 nM sar1 T39N or 100 M guanylylimidodiphosphate (GMP-PNP)
were included to block COPII budding or uncoating, respectively. After
incubation at 32°C for 30 min to allow vesicle release, cells were removed by
centrifugation at 4000  g for 1 min followed by 15,000  g for 1 min. The
supernatant, which contains released COPII vesicles, was then supplemented
with test proteins such as GST-ALG2 or chelators and incubated another 1 h
at 32°C to allow tethering and fusion. The suspension of tethered/fused
vesicles was then subjected to immunoisolation. This was accomplished by
addition 5 g of anti-myc antibody and incubation for 2 h at 4°C with
end-over-end rotation at 3 rpm. The suspension was then supplemented with
15 l (packed) of protein A-Sepharose beads (preblocked in 5 mg/ml BSA and
5 mg/ml PVP-40T in 25/125 buffer) and incubated at 4°C overnight with slow
end-over-end rotation. Beads were washed four times by centrifugation at
375  g for 1 min and resuspension in 25/125 buffer containing 1 mg/ml BSA.
During the last wash, resuspended beads were transferred to a fresh tube.
After the washes, proteins were eluted from the beads by addition of 50 l of
0.1 M glycine, pH 2.5, mixing, centrifugation at 375  g for 1 min, and
removing the supernatant to a tube containing 7.5 l of 2 M Tris, pH 8.0.
Elution was repeated twice more into this eluate pool (157.5 l of total eluate),
and the eluate pool was placed into a Microcon YM-10 ultrafiltration device
(Millipore, Billerica, MA) and centrifuged to dryness. The sample on the
membrane was dissolved in 25 l of SDS sample buffer and analyzed by
4–20% gradient SDS-PAGE gels and immunoblotting.
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Chelator Studies
Under our basal in vitro assay conditions described above, in the absence of
“test” chelators, our fusion reactions were weakly Ca2 buffered to approx-
imately resting cytosolic free Ca2 conditions. In the presence of 500 M
EGTA, 2.5 mM total Mg2, 180 M total CaCl2, at pH 7.2, calculations suggest
63 nM free Ca2(Portzehl et al., 1964). This minimal buffering system was
necessary to offset variations in Ca2 that might be present in different
batches of cytosol and other reagents used in experiments but was easily
superseded by adding millimolar concentrations of chelators that are typi-
cally necessary to neutralize biological Ca2 transients. For example, addition
of an extra 5 mM EGTA, as in Figure 3A, is calculated to reduce equilibrium
free Ca2 10-fold to 3.6 nM.
RESULTS
Luminal Ca2 Regulates Membrane Trafficking in the
Early Secretory Pathway
Past studies on the role of Ca2 in the biosynthetic secretory
pathway have relied on membrane-permeant chelators that
chelate cytosolic as well as luminal Ca2 (Chen et al., 2002)
and thus do not elucidate a specific role for luminal Ca2 per
se. To begin to examine the role of luminal calcium in
ER-to-Golgi trafficking, we used CPA, a reversible inhibitor
of the sarco/endoplasmic reticulum Ca2-ATPase (SERCA)
(Mason et al., 1991). NRK cells were treated with CPA, and
the distribution of the ER-to-Golgi SNARE rbet1, a type II
integral membrane protein, was examined at various time
points. If subtle changes in membrane flux between the ER
and Golgi occurred, rbet1 distribution should be a sensitive
indicator, because rbet1 rapidly cycles between the ER and
Golgi and is largely localized to the ERGIC at steady state
(Hay et al., 1998). As shown in Figure 1A, CPA treatment in
Ca2-free medium for 15 min followed by a 15-min chase
period in Ca2-free medium resulted in a change in the
appearance of rbet1. Control cells exhibit strong rbet1 label-
ing in the perinuclear area surrounding the Golgi marked by
GM130 and fainter punctate structures in the peripheral
cytoplasm that are not associated with Golgi. CPA-treated
cells, in contrast, displayed relatively more intense punctate
peripheral rbet1-positive objects compared with the perinu-
Figure 1. Luminal Ca2 regulates size of rbet1-positive pre-Golgi structures. (A) NRK cells were either mock treated, incubated at 15°C for
30 min, or treated with CPA to deplete luminal Ca2 (see Materials and Methods), and then fixed and immunostained for rbet1 and the Golgi
marker GM130. Shown are single focal planes from deconvolved widefield image stacks. (B) Cytosolic Ca2 dynamics during the CPA
regimen to deplete luminal Ca2. Fluorescence ratios are calibrated to free Ca2 values in Supplemental Figure S1A. (C) Luminal ER Ca2
dynamics during the CPA regimen. Fluorescence ratios are calibrated to free Ca2 values in Supplemental Figure S1B. (D–F) Quantitation of
peripheral rbet1-positive objects in experiments such as described in A. Values represent per cell means derived from at least 20 randomly
chosen cells. Error bars display SE. CX, cycloheximide; Tg, thapsigargin. In F, only objects that fall within the size bins indicated above
each plot are included in each panel. Selected p values from two-tailed Student’s t test are included. Areas of objects were calculated
assuming that one image pixel width calibrates to 224 nm in the cell. Single-pixel objects (with calculated area 0.05 m2) are subresolution
but were not eliminated from the size analysis; they did not contribute to the 0.2–0.45 m2 and 0.45 m2 size bins in F.
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clear labeling. This change did not result from a dispersal of
Golgi into the peripheral cytoplasm, as indicated by the
GM130 labeling. As also shown in Figure 1A, the overall
effect of CPA seemed similar to that when the cells were
incubated at 15°C, a treatment that is commonly used to trap
anterograde cargo and vesicle machinery in swollen, periph-
eral ERGIC structures (Saraste and Svensson, 1991).
To confirm that our protocol achieved specific depletion of
luminal Ca2 as intended, we used live imaging of luminal
(Figure 1C and Supplemental S1B) and cytosolic (Figure 1B
and Supplemental S1A) Ca2. Ca2 concentrations were
determined using transfected chameleon biosensors D1ER
(Palmer et al., 2004) and YC3.6 (Nagai et al., 2004) that have
optimal affinities for the free Ca2 concentrations in the
respective compartments. Treatment with 10 M CPA re-
sulted in a severe depletion of ER luminal free Ca2 within
10 min of addition, from 385 M, a typical resting value for
cultured mammalian cells (Osibow et al., 2006; Malli et al.,
2008), to 23 M; this means that vesicular COPII-derived
membranes generated from the ER after 10 min must also be
depleted of vesicular Ca2. As expected, cytosolic Ca2
underwent an extreme increase as the luminal compartment
was emptied, but this was cleared and restored to the resting
value of 45–50 nM after 15 min of CPA addition. We con-
clude that by the end of the 15-min CPA treatment and start
of the chase period, luminal Ca2 is depleted by 90% and
cytosolic Ca2 is at resting levels. Furthermore, this condi-
tion seems to remain stable during the chase period after
CPA washout.
The increased peripheral rbet1 staining during CPA treat-
ment can be observed quantitatively by measuring the av-
erage area of peripheral rbet1-positive objects over time
(Figure 1D). The area of an average peripheral rbet1-positive
structure more than doubled during the standard treatment
condition of 15-min CPA plus 15 min Ca2-free chase. Most
of the increase occurred during the chase period during
which the desired condition of specific luminal depletion
was achieved. Chase for an additional 15 min (30-min total)
led to a slight decrease in object size; however, we believe
this apparent decrease was an artifact of a gross morphology
change in the cells, which began to round up during this
interval. We compared the effect of CPA treatment on pe-
ripheral object size to other treatment conditions (Figure 1E).
Luminal Ca2 depletion by CPA treatment for 15 min and
chase for 15 min caused a significantly more dramatic in-
crease in object size than 15°C treatment for 30 min. CPA
plus cycloheximide gave similar results to CPA, but less
dramatic, demonstrating that the growth of rbet1 peripheral
objects involves mostly redistribution of existing rbet1
rather than recruitment of newly synthesized protein. Cy-
cloheximide also blocks the accumulation of unfolded pro-
teins during ER luminal Ca2 depletion and Ire1p-depen-
dent transcriptional activation of ER stress response
elements (Haze et al., 1999; Rüegsegger et al., 2001); thus, ER
stress responses related to the accumulation of unfolded
proteins seem unlikely to be an important determinant of
the rapid changes in ERGIC structure observed with CPA.
Thapsigargin, a distinct SERCA inhibitor (Mason et al.,
1991), caused a similar effect on mean object size, confirming
the mechanism of the CPA effect.
To observe subtle changes in size distribution, peripheral
rbet1 objects were binned according to size (Figure 1F).
Although the number of small objects (0.2 m2) remained
virtually unchanged in CPA-treated cells, CPA treatment
clearly generates a new population of objects 0.45 m2.
Interestingly, the 15°C treatment resulted in a different dis-
tribution of object sizes than the luminal Ca2 depletion.
Although 15°C caused an overall increase in the number of
objects, most of the increase occurred in the 0.2-m2 size
range, rather than in the large size bin as for CPA. We also
noticed that the preferential creation of large objects by CPA
treatment occurred at earlier time points (data not shown),
indicating that increased numbers of small objects is not a
kinetic intermediate on-pathway to the CPA effect of in-
creased large objects. This suggests that the trafficking
step(s) affected by the two treatments is distinct. For exam-
ple, the CPA effect would be consistent with overactive
fusion of COPII vesicles and VTCs and/or a lack of recycling
from them, whereas the 15°C phenotype would be more
consistent with a buildup of vesicles/VTCs due to a lack of
microtubule-dependent transport.
Total rbet1 labeling intensity increased significantly in the
CPA and 15°C treated cells (Supplemental Figure S2A). This
could indicate either that more rbet1 was present after these
treatments or that the pool of rbet1 in the trapped interme-
diates was more accessible for immunofluorescence labeling.
This increase was specific to the rbet1 mAb used; in the same
cells, total GM130 labeling intensity did not change (Supple-
mental Figure S2B). In addition, another protein that cycles
rapidly through VTCs, p24, did not increase significantly in
total intensity (Supplemental Figure S2D). Furthermore,
rbet1 in the cell population did not change significantly as
assessed by quantitative Western blotting (Supplemental
Figure S2C). We conclude that the 16G6 N-terminal rbet1
epitope is more accessible in the swollen structures, perhaps
indicating a change in SNARE protein interactions.
To test whether the luminal Ca2 effect was specific to the
rbet1 protein per se, the distribution of the rapidly recy-
cling vesicle marker p24 was examined. As shown quali-
tatively in Figure 2A, p24 also increased in Golgi-negative,
punctate peripheral objects upon luminal Ca2 depletion.
This change was similarly reflected quantitatively by a dra-
matic increase in the number of p24 objects 0.45 m2
(Figure 2C). However, unlike for rbet1, there was not a signif-
icant increase in p24 total integrated staining intensity (Supple-
mental Figure S2D). In conclusion, multiple ERGIC markers,
and not just ER/Golgi SNAREs, rapidly accumulate in large
peripheral structures upon luminal Ca2 depletion.
The enlarged objects represent pre-Golgi intermediates
because they are negative for Golgi markers; other possibil-
ities include ER exit sites (ERESs) or vesicular tubular clus-
ters (VTCs). We examined sec16, an ERES scaffold protein
that is not part of the COPII vesicle coat per se (Hughes et al.,
2009). As shown qualitatively in Figure 2B and quantita-
tively in Figure 2D, the number of above-threshold sec16-
positive objects did not change significantly upon CPA treat-
ment, in contrast to rbet1 objects quantified in the exact same
cells. Hence, the enhanced peripheral structures do not seem
to be caused by a general expansion or proliferation of ERES.
Our results are consistent with a previous study using mem-
brane-permeant chelators concluding that Ca2 was in-
volved at a post-ER but pre-Golgi step in VSV-G-green
fluorescent protein (GFP) transport (Chen et al., 2002). If the
expanded objects represent early-stage VTCs, one would
expect them to be closely associated with both ERES as well
as COPI components, due to the immediate proximity of
nascent VTCs to ERES and their capacity to recruit COPI
shortly after formation (Aridor et al., 1995; Rowe et al., 1996).
For each cell in the populations quantified in Figure 2B after
CPA treatment, the largest rbet1 peripheral structures, i.e.,
those most likely to represent a specific result of Ca2 de-
pletion, were analyzed in greater detail. In 98% of cases,
these rbet1 objects overlapped by at least 50% of their area
with a sec16 object. A similar experiment was carried out
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using rbet1/-COP costaining and CPA treatment. In 73% of
cases, the largest peripheral rbet1 objects overlapped by at
least 50% of their area with a -COP–positive object (Sup-
plemental Figure S2E). We can thus estimate that at a min-
imum, 71% of the largest rbet1 objects are positive for both
COPI and ERES markers. This represents a rather conspic-
uous congruence of COPI and ERES markers with the en-
larged rbet1-labeled structures. Due to the relative lack of
CPA effect on ERES markers in combination with the close
association of the enlarged objects with both COPI and
ERES, the most likely identity of the expanded objects are
the post-ER, pre-Golgi carriers known as VTCs, elements of
the ERGIC. However, electron microscopy analysis is re-
quired to distinguish whether the enlarged anterograde
structures are physically distinct from versus still connected
to ERES.
A recent report by Amodio et al. (2009) highlighted the
accumulation of anterograde cargo and vesicle machinery in
the ER and ERES upon 2-h thapsigargin treatment in the
presence of normal extracellular Ca2. Furthermore, these
experiments documented multiple stress-induced morpho-
logical changes such as Golgi fragmentation that were not
present in the present studies. Because the Amodio condi-
tions would have resulted in very high and sustained cytosolic
Ca2 over a much longer timeframe than in our own experi-
ments, it seems likely that our differing conclusions may rep-
resent results of very different experimental conditions.
In conclusion, the experiments of Figures 1 and 2 establish
for the first time that luminal Ca2 plays an important role
in ER-to-Golgi trafficking organelles. Depletion of luminal
Ca2 may cause overactive COPII vesicle fusion and/or
defects in sorting/recycling to the ER, resulting in expanded
peripheral VTC-like organelles.
Vesicular Ca2 Normally Restrains In Vitro COPII
Vesicle Fusion and Contents Mixing
To identify mechanisms by which luminal Ca2 may mod-
ulate the structure and function of secretory intermediates,
Figure 2. Luminal Ca2 regulates the size of ERGIC but not ERES structures. (A) NRK cells were either mock treated or treated with CPA
to deplete luminal Ca2 (see Materials and Methods), then fixed and immunostained for p24 and the Golgi marker mannosidase II. Shown are
single focal planes from deconvolved widefield image stacks. (B) Immunolabeling for rbet1 and sec16 under the same experimental
conditions as described in A. (C) Quantitation of numbers of peripheral p24-positive objects in three size bins under the experimental
conditions shown in A. (D) Quantitation of peripheral objects positive for rbet1 and sec16 from the experiment shown in B. All size bins were
included in one analysis. The rbet1 and sec16 object data are from precisely the same set of double-labeled cells. Values represent means
derived from at least 20 randomly chosen cells. Error bars display SE. Selected p values from two-tailed Student’s t test are included.
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we used an established cell-free reconstitution of homotypic
COPII vesicle fusion (Xu and Hay, 2004; Bentley et al., 2006;
Yu et al., 2006; Cai et al., 2007). COPII vesicles generated in
vitro from permeabilized NRK cells possess or recruit all
components necessary for efficient tethering and fusion to
generate pre-Golgi intermediates resembling cellular VTCs
(Xu and Hay, 2004). Membrane fusion and contents mixing
is scored biochemically by the heterotrimerization of radio-
active VSV-G* with nonradioactive VSV-G-myc present ini-
tially in distinct COPII vesicle populations. Heterotrimers
are easily assayed by detergent solubilization of vesicles,
immunoprecipitation using anti-myc antibodies, and auto-
radiography to detect the radioactive subunits (Xu and Hay,
2004). It has been speculated that luminal Ca2 would most
likely affect membrane trafficking at the cytoplasmic surface
of membranes after its efflux by regulated or nonspecific
processes (Wahl et al., 1992; Camello et al., 2002; Burgoyne
and Clague, 2003; Hay, 2007). As shown in Figure 3A, ad-
dition of the fast, membrane-impermeant Ca2 chelator
BAPTA resulted in stimulation of heterotrimer production
by as much as eightfold (Figure 3A, pos. vs. 2 mM BAPTA).
Among different experiments, the stimulation ranged from
three- to eightfold over the unstimulated control. The in-
crease in heterotrimers was not solely due to an effect of
BAPTA on heterotrimer stability in solution or recovery by
immunoprecipitation, because BAPTA stimulated in a time-
dependent manner during the fusion reaction (see below;
Figure 6) and because addition of BAPTA to fusion reactions
on ice, after the fusion reaction but before detergent addi-
tion, did not recapitulate the effect (Figure 3A, 2 mM
BAPTA, on ice). Finally, a much slower chelator of similar
affinity for Ca2, EGTA, did not stimulate like BAPTA, even
at higher concentrations (Figure 3A, 5 mM EGTA). The
stimulation of fusion by BAPTA suggests that Ca2 nor-
mally suppresses fusion, and this suppression is relieved
upon Ca2 chelation.
To test whether the dramatic and unexpected effects of
BAPTA on fusion were due to Ca2 chelation as opposed to
some other direct action of BAPTA on proteins or mem-
branes, we analyzed the BAPTA sensitivity of fusion in the
presence of different bulk free Ca2 concentrations. As
shown in Figure 3B, the presence of excess free Ca2 shifted
the BAPTA stimulation curve to the right, delaying stimu-
lation until the BAPTA concentration significantly exceeded
that of bulk added Ca2. This indicates that Ca2-free
BAPTA, but not Ca2-saturated BAPTA, is an active species
in our assay and is highly consistent with BAPTA acting, at
least in part, through Ca2 chelation. Importantly, it rules
out most nonspecific effects that could be caused by high
concentrations of this molecule.
The structures of BAPTA and EGTA are shown in Figure
3C. Although these two chelators buffer Ca2 to approxi-
mately the same levels at equilibrium, under typical exper-
imental conditions BAPTA reaches equilibrium and thus
neutralizes a cellular Ca2 gradient 1000-fold faster than
EGTA (Burgoyne and Clague, 2003, and references therein).
Taking into account the estimated diffusion rate of Ca2 in
cytosol, this may mean that EGTA can never neutralize Ca2
gradients within 20 nm of an active egress site, whereas
BAPTA can. Hence, selectivity of BAPTA over EGTA has in
Figure 3. BAPTA, but not EGTA, stimulates
COPII vesicle fusion. (A) Homotypic COPII
vesicle fusion measured using the in vitro
VSV-G heterotrimer cargo mixing assay. The
no myc control includes radioactive VSV-G*
vesicles, but not VSV-G-myc vesicles, to con-
trol for the specificity of the anti-myc immu-
noprecipitation. BAPTA and EGTA were in-
cluded in fusion reactions at the indicated
concentrations. The on ice reactions had the
indicated chelators added after the fusion in-
cubation, before detergent solubilization, to
control for possible nonfusion-related effects of
the chelators. (B) Titration of fusion reactions
with BAPTA in the presence and absence of
excess free Ca2. Because the BAPTA stimula-
tion curve is pushed to the right, it seems that
only free BAPTA, and not the Ca2-bound
chelator, has a stimulatory effect on heterotri-
mer formation. (C) Structures of EGTA (black)
and BAPTA (black plus red). (D) Effects of
aminomethoxy (/AM) derivatives of BAPTA
and EGTA on homotypic COPII vesicle fusion.
Both /AM esters were able to partially mimic
the effects of BAPTA, suggesting that the se-
lective effects of BAPTA were due to its ability
to rapidly chelate escaping luminal Ca2. Fu-
sion assay data are presented as means of du-
plicate determinations with error bars repre-
senting SE where larger than symbol size.
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most cases been interpreted to indicate that the Ca2 sen-
sor/effector mechanism is either very rapid and/or very
close to the source of Ca2, most likely a channel (Burgoyne
and Clague, 2003; Hay, 2007). One could even postulate that
Ca2 constitutively leaking from the lumen of secretory
intermediates could create a steady-state region of elevated
Ca2 near the membrane that could persist in EGTA but not
in BAPTA (Hay, 2007). If neutralization of Ca2 gradients is
involved in the BAPTA stimulation of our fusion assay, then
the source of the active Ca2 may be the vesicle lumen.
Furthermore, functional chelation of Ca2 at the source
should not require an especially fast chelator. To test this
possibility, we analyzed the effects of the membrane-per-
meant aminomethoxy ester derivatives of BAPTA and
EGTA, BAPTA/aminomethoxy (AM) and EGTA/AM. As
shown in Figure 3D, both membrane-permeant derivatives
comparably stimulated the heterotrimer assay at concentra-
tions up to 0.3 mM. Unfortunately, we were unable to inter-
pret results at higher concentrations—hydrolysis of these
compounds in cytosol can generate formaldehyde and acetic
acid—perhaps explaining why both chelators inhibited our
assay at millimolar concentrations (data not shown). The
partial recapitulation of the BAPTA stimulatory effect by
both EGTA/AM and BAPTA/AM (Figure 3D) but not by
EGTA (Figure 3A) is highly consistent with the interpreta-
tion that it is the egress of luminal Ca2 that normally has a
suppressive effect on COPII vesicle fusogenicity.
Ca2 and ALG-2 Promote Retention of COPII Coat
Components on Pre-Golgi Intermediates
To gain more insight into the molecular mechanisms by
which vesicular Ca2 regulates VTC morphology and fu-
sion, we analyzed nascent pre-Golgi intermediates for the
presence of several peripheral membrane proteins that could
potentially affect fusion efficiency. After in vitro tethering/
fusion reactions with no chelator, BAPTA, or EGTA, intact
pre-Golgi intermediates containing VSV-G-myc cargo were
immunoisolated using anti-myc antibody and subjected to
immunoblotting. As shown in Figure 4A, the integral mem-
brane components VSV-G-myc, p24 and rbet1, demonstrate
the specificity of the immunoisolation (control  vs. control
; also note enrichment in the isolated fractions relative to
starting material). Furthermore, the specificity of COPII-
dependent budding is demonstrated by the lack of ER resi-
dent proteins (IP3 receptor in A, and PDI in C), and by the
inhibition of specific product when purified sar1 T39N was
included at the budding stage (sar1 T39N). The yield of
vesicles seemed to be slightly higher in the BAPTA-treated
samples as judged by the band intensities of all three inte-
gral membrane proteins. When the same blot was probed for
peripheral membrane proteins, two patterns emerged. The
golgins GM130 (A) and p115 (B), and the COPII inner shell
component sec23 (A and B), seemed to generally follow the
recovery of the integral membrane proteins, indicating that
the chelators did not significantly change their abundance
on membranes. In stark contrast, the COPII outer shell com-
ponent sec31, as well as the COPI subunit COP, were
extracted to background levels by BAPTA and were not
affected by EGTA. The completeness and specificity of this
depletion was reproduced in numerous experiments. These
data parallel the functional impact of BAPTA and EGTA on
fusion and suggest that residual coats could suppress fusion
as effectors of luminal Ca2.
Figure 4. Luminal Ca2 and ALG-2 regulate
the retention of select coat subunits on pre-
Golgi fusion intermediates. (A) BAPTA specif-
ically extracts select COPI and COPII subunits
from forming pre-Golgi intermediates. Homo-
typic fusion in vitro assays were conducted in
the absence or presence of 2 mM BAPTA or
EGTA (indicated above), and immunoisolated
using anti-myc antibodies. Vesicles were gen-
erated from VSV-G-myc transfected cells ()
or nontransfected cells () to demonstrate
specificity of isolation. In addition, 1 M puri-
fied sar1 T39N was included during the bud-
ding stage to demonstrate that the isolated
intermediates are COPII derived. Immunoblot-
ted proteins are indicated along left edge.
IP3R3, a resident ER membrane protein, addi-
tionally demonstrates specificity of budding.
(B) Quantitation of a similar immunoisolation
experiment (see blot in Supplemental Figure
S3). In this experiment, it can be seen that
peripheral membrane protein ALG-2 is also
sensitive to BAPTA, but p115 is not. (C) Similar
immunoisolation experiment where purified
ALG-2 is present during the fusion experi-
ment. ALG-2 caused a dramatic retention of
outer shell component sec31 but not the COPI
component -COP. The absence of ER resident
luminal protein PDI demonstrates specificity
of the intermediates isolated. A star indicates
the position of cross-reactive antibody heavy
chain bands. GMP-PNP shows an estimate of
components present on a fully coated vesicle as opposed to components remaining on tethered/fused pre-Golgi intermediates (D)
Quantitation of experiment from C. For quantitations (B and D), band intensities were normalized to the recovery of cargo VSV-G-myc in
each condition before plotting them on a relative scale with the highest recovery set to 1. Differences in band intensities seen in the input cells
lanes (A) were caused by using slightly denser cell suspensions for the nontransfected cell controls.
M. Bentley et al.
Molecular Biology of the Cell1040
These experiments also reveal a semiquantitative picture
of residual COPII coat retention during homotypic COPII
vesicle tethering/fusion in vitro. The experiment shown in
Figure 4C and quantified in Figure 4D included a GMP-PNP
condition in which this nonhydrolyzable GTP analogue was
present from the outset of budding and then throughout the
tethering/fusion reaction. By preventing GTP hydrolysis on
sar1, GMP-PNP locks the coat onto COPII vesicles (Barlowe
et al., 1994) and is used here as a standard to represent the
components of a fully coated vesicle. Note the dramatic
difference between inner and outer shell retention on teth-
ered/fused pre-Golgi intermediates and fully coated vesi-
cles. Normal tethered/fused intermediates possess 55% of
the inner shell component sec23 compared with GMP-PNP
vesicles (Figure 4D, middle, cont. vs. GMP-PNP). In Cai et al.
(2007), a similar experiment produced a value of 58%. Thus,
the inner shell is relatively stably associated after budding—
the 55% could easily be an underestimate due to coat loss
during washing of immunoisolates. In contrast, the outer
shell component sec31 is recovered in tethered/fused inter-
mediates at only 15% of its GMP-PNP value (Figure 4D,
left, cont. vs. GMP-PNP). This number varies between ex-
periments to as low as 6%. Hence, the outer shell can be shed
independently of the inner shell and remains at much
smaller fractions during tethering/fusion and then rigorous
washing of immunoisolates. We do not know a precise value
for fractional coat retention required to have a regulatory
consequence on tethering and fusion. However, a fully
coated vesicle contains so much coat protein that it exhibits
dramatically altered physical and morphological properties;
it is easy to imagine that even 15% of the original outer shell
would still be a very abundant peripheral membrane protein
and could regulate important aspects of vesicle function.
Both COPI and COPII coats have been suggested to be
regulated by Ca2. COPI, which is recruited to our assem-
bling VTCs but is not strictly required for fusion of COPII
vesicles with each other (Xu and Hay, 2004), has been dem-
onstrated to require Ca2 for maximal recruitment to Golgi
(Ahluwalia et al., 2001); no Ca2 sensor molecule has been
suggested for COPI. For COPII in contrast, a potential Ca2
sensor is known: ALG-2 is a penta-EF-hand protein present
at ERES that seemed to stabilize sec31 on the membrane but
was not required for ERES formation or function (Yamasaki
et al., 2006). We reasoned that ALG-2 could potentially have
a dramatic effect on residual vesicle coat retention, because
other COPII stabilizing influences present at ERES, such as
sar1 guanine nucleotide exchange factor and ERES scaffold
proteins would be absent at this stage. We first asked
whether ALG-2 was restricted to ERES or whether it was
also present on COPII vesicles and their fusion products.
ALG-2 is an abundant component of liver cytosol and un-
fortunately displays high nonspecific binding to surfaces.
However, despite a high background in our immunoisola-
tion procedure, there was a definite association of ALG-2
with assembling pre-Golgi intermediates (Figure 4B, bottom
left, no myc vs. control; unquantified blot shown in Supple-
mental Figure S3). Furthermore, the specific ALG-2 signal
was removed by BAPTA treatment, consistent with ALG-2
regulating coat retention as a function of Ca2 (Figure 4B,
bottom left, control vs. BAPTA).
If, as suggested above, ALG-2 regulates coat retention on
pre-Golgi intermediates, then increased ALG-2 should cause
excessive coat retention. This was tested using purified re-
combinant ALG-2 in the COPII vesicle assembly assay/
immunoisolation. As shown qualitatively in Figure 4C and
quantitatively in Figure 4D, addition of 1 M ALG-2 to
COPII vesicle fusion assays led to a dramatic increase in
sec31 retention on VSV-G-myc–containing intermediates.
The increase in abundance of sec31 was 10-fold over con-
trol sec31 retention and even increased approximately two-
fold greater than that caused by inclusion of GMP-PNP
(Figure 4D, left, cont. vs. ALG-2). This increase in the COPII
outer shell occurred mostly independently of the inner shell
component sec23, whose abundance increased less than
twofold (Figure 4D, middle, cont. vs. ALG-2). Also note that
ALG-2 did not affect the abundance of COPI component
COP (Figure 4D, right, cont. vs. ALG-2). This suggests that
COPI is recruited to and stabilized to pre-Golgi interme-
diates by a completely independent Ca2-dependent
mechanism.
In summary, Figure 4 demonstrates that Ca2 stabilizes
components of both COPII and COPI on pre-Golgi interme-
diate membranes. For COPII, the mechanism of stabilization
can involve the Ca2 sensor ALG-2, which primarily stabi-
lizes the COPII outer shell. Modulation of residual outer
shell COPII coat components by ALG-2 could potentially
provide a mechanism by which luminal Ca2 affects the
structure and function of VTCs in cells (Figures 1 and 2) and
by which vesicle-associated Ca2 suppresses homotypic
COPII vesicle fusion in vitro (Figure 3).
ALG-2 Regulates In Vitro COPII Vesicle Contents Mixing
in a Ca2-dependent Manner
Despite a clear effect of ALG-2 and Ca2 on the quantity of
sec31 at ERES, a functional effect on vesicle budding was not
observed (Yamasaki et al., 2006). We wondered whether
Ca2-dependent retention of sec31 by ALG-2 might be more
functionally rate limiting at a postbudding step. To test this
possibility directly, we added purified recombinant GST-
ALG-2 or GST to tethering/fusion reactions and monitored
fusion using the VSV-G heterotrimer assay. As shown in
Figure 5A, GST-ALG-2 potently inhibited COPII vesicle fu-
sogenicity in a dose-dependent manner, with maximal inhi-
bition achieved by 1 M protein. To test whether ALG-2
inhibition of fusion required Ca2 binding capacity, we
added GST-ALG-2 E47,114A, a mutant in which two EF-
hands are disrupted and which exhibits dramatically re-
duced Ca2 binding (Lo et al., 1999). The inhibitory proper-
ties of this protein were greatly reduced, suggesting that the
wild-type protein uses Ca2 binding to exert its inhibitory
effect. The recombinant proteins, which were expressed and
purified at equivalent abundance and solubility, are shown
in Figure 5B.
To further explore the relationship between ALG-2, vesic-
ular Ca2, and BAPTA, we tested the inhibitory properties
of ALG-2 in the presence and absence of BAPTA. As can be
seen in Figure 5C (left), in the absence of BAPTA, we used a
dose of GST-ALG-2 that inhibited fusion by 50%. As be-
fore, the same concentration of the E47,114A mutant inhib-
ited only slightly. We also included anti-syntaxin 5 antibody
at a concentration that inhibits fusion by 50% as well. This
antibody has been well characterized as an inhibitor of in
vitro fusion assays (Williams et al., 2004; Xu and Hay, 2004;
Bentley et al., 2006); at the concentration used here, fusion is
partially inhibited but not tethering (Bentley et al., 2006). In
Figure 5C (right), the same inhibitors were tested in the
presence of BAPTA during the same experiment, leading to
several observations. First, the Ca2-dependent component
of ALG-2 inhibition is effectively negated—wild-type and
E47,114A mutant inhibit to approximately the same small
degree. This indicates that Ca2 chelation by BAPTA com-
pletely reverses the mechanism by which ALG-2 inhibits
fusion, consistent with that mechanism being stabilization of
sec31, which BAPTA extracts from membranes. Second, the
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BAPTA-dependent fusion signal is still largely sensitive to
anti-syntaxin 5 antibody, indicating that SNARE-dependent
membrane fusion is required for the BAPTA stimulation of
heterotrimer formation. In summary, the experiments in
Figure 5 demonstrate that ALG-2, through Ca2-dependent
stabilization of the COPII outer shell, can restrain membrane
fusion or membrane mixing (see below). Thus, ALG-2 is a
very good candidate to mediate the effects of luminal Ca2
on VTC morphology and size (Figures 1 and 2) and to
mediate the suppression of fusogenicity relieved by BAPTA
(Figures 3 and 5).
ALG-2 Inhibits Heterotrimerization via a Prefusion
Mechanism
Although the heterotrimer assay strictly depends upon
membrane fusion, there are actually two fundamentally dis-
tinct mechanisms by which ALG2-dependent residual coat
retention could affect the fusion signal. As diagrammed in
Figure 6A, dashed box area, residual COPII stabilization
could either 1) act via a prefusion mechanism by inhibiting
close vesicle approach, fusion machinery availability, and/
or docking (bottom intermediate in the dashed box); or 2)
limit postfusion membrane mixing by maintaining mem-
brane microdomains that prevent mixing of cargo from
fused or hemifused vesicles (top outcome). Although the
outer shell does not directly bind cargo, its presence could
affect cargo mixing by binding and immobilizing the cargo-
bound inner shell. It could also sterically prevent the con-
version from hemifusion to full fusion by limiting mem-
brane flow into the fusion pore. Importantly, the two very
distinct mechanisms outlined are not mutually exclusive
and either could potentially exert a strong impact on pre-
Golgi intermediates under different conditions. To distin-
guish between prefusion and postfusion inhibition by
ALG-2, we performed the experiment diagrammed in Fig-
ure 6A. A first fusion incubation was performed in the
presence of a partially inhibitory concentration of recombi-
nant ALG-2 to stabilize the COPII outer shell. The first
incubation should result in intermediates depicted in the
dashed box; the second incubation will distinguish which
are predominant. During the second incubation, BAPTA
Figure 5. ALG-2 regulates in vitro COPII vesicle homotypic fusion
in a Ca2-dependent manner. (A) Homotypic COPII vesicle fusion
measured using the in vitro VSV-G heterotrimer cargo mixing as-
say. Purified GST, GST-ALG-2 wild-type, or GST-ALG-2 E47,114A
mutant proteins were included in fusion incubations at the indi-
cated concentrations. The ice control includes radioactive VSV-G*
vesicles and VSV-G-myc vesicles, but the low temperature prevents
a specific fusion signal. (B) PAGE gel on purified proteins used in A
and C, stained with Coomassie Blue. Proteins were used in fusion
assays in the same proportions as on the gel. (C) Fusion experiment
using partially inhibitory doses of the proteins indicated along the
bottom. The left panel experiment was conducted in the absence of
BAPTA. The right panel experiment was conducted, in the same
experiment, in the presence of 2 mM BAPTA. Fusion values for both
panels are normalized to the positive control signal in the absence of
BAPTA (set to 100%). BAPTA negates the specific inhibitory effect of
GST-ALG-2 but not that of anti-syntaxin 5 antibody. Fusion assay
data are presented as means of duplicate determinations, with error
bars representing SE where they are larger than symbol size.
Figure 6. ALG-2–dependent coat retention primarily inhibits via a
prefusion mechanism. (A) Outline of experiment to distinguish
between pre- or postfusion mechanisms by which ALG-2 inhibits
heterotrimer assay (see text for explanation). Cargos VSV-G-myc
and radioactive VSV-G* are depicted in green and red, respectively.
COPII coat is represented by thick black lines. (B) Heterotrimer data
from experiment depicted in A. Heterotrimers are normalized with
100% representing the amount produced during the first incubation
in the absence of recombinant ALG-2, before addition of BAPTA
and second incubation. BAPTA was omitted from the conditions
plotted at time 0; BAPTA was added to all other conditions, while
on ice, just before beginning the second incubation at 32°C. ALG-2
added during the first incubation had a dramatic consequence on
the subsequent heterotrimer signal (red vs. blue lines), but ALG-2
added only during the second incubation had no influence (green
square). Plotted are means of duplicate reactions, with error bars to
represent SE where they exceeded symbol size.
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will be present to reverse ALG-2 stabilization of the COPII
coat, a manipulation suggested by the known ability of
BAPTA to negate ALG-2 inhibition (Figure 5C). This second
incubation will freely permit late events in our assay such as
the completion of membrane mixing and heterotrimeriza-
tion, but it will be biased against early steps in membrane
fusion for two reasons: 1) first, membrane fusion in this
assay generally reaches a maximum after 1 h (the length of
the first incubation), presumably as needed components are
exhausted (Supplemental Figure S4); and 2) we added -sol-
uble N-ethylmaleimide-sensitive factor attachment protein
(-SNAP) L294A, a dominant-negative inhibitor of N-ethyl-
maleimide sensitive factor-dependent SNARE recycling,
during the second incubation to inhibit the availability of
free SNAREs for new rounds of fusion (Bentley et al., 2006).
If ALG-2 inhibited via a postfusion mechanism, the final
outcome after the second incubation would be that of un-
impaired heterotrimerization (Figure 6A, top right out-
come). However, if ALG-2 inhibits via largely prefusion
mechanisms, the inability to support new rounds of fusion
during the second incubation should result in a permanent
inhibition of heterotrimerization (Figure 6A, bottom right
outcome).
Figure 6B shows heterotrimer formation over time during
the second stage incubation. When vesicles were first incu-
bated without ALG-2, and then incubated with BAPTA, a
rapid and robust amplification approaching sevenfold of the
heterotrimer signal was obtained (red line). In stark contrast,
the vesicles that had been incubated with ALG-2 during the
first incubation were severely hampered for heterotrimer
formation, reaching an apparent maximum at threefold
stimulation. Importantly, ALG-2 influenced the experiment
only during the first incubation, because addition of ALG-2
along with BAPTA only during the second incubation
reached a similar maximum as BAPTA alone (Figure 6B,
green square symbol at 30 min). The inability of ALG-2–
preincubated vesicles to recover a robust fusion signal in the
presence of BAPTA implies that ALG-2–dependent coat
retention inhibits largely at an early, prefusion stage of the
assay, for example SNARE-dependent docking. On the other
hand, the ability of BAPTA to robustly stimulate heterotri-
merization of the control vesicles during the second incuba-
tion implies that under basal conditions, the 10% of resid-
ual sec31 must limit later stages in fusion or postfusion
events. The experiment in Figure 3C does not define a pre-
cise stage at which BAPTA stimulates other than that it
seems to be later than the prefusion stage at which ALG-2
inhibits (see Discussion). In total, the experiment demon-
strates that ALG-2–dependent coat retention inhibits homo-
typic COPII vesicle fusion at a prefusion step, and implies
that different degrees of coat retention may inhibit different
stages of fusion and membrane mixing.
DISCUSSION
Our results include the somewhat surprising finding that
Ca2 suppresses membrane fusion in the early secretory
pathway. This contrasts with several other membrane traf-
ficking steps, such as regulated exocytosis, endosome fusion,
and intra-Golgi transport, where a stimulatory role for Ca2
has been documented (for reviews, see Burgoyne and
Clague, 2003; Hay, 2007). We can only speculate that ER-to-
Golgi transport represents an ideal opportunity for cellular
machinery to use luminal Ca2 in a complex, graded, op-
portunistic manner. The ER normally contains a very high
free Ca2 concentration (Supplemental Figure S1B, 386 M
in living NRK cells); because SERCA pumps are retained in
the ER and do not enter COPII vesicles, it is assumed that
nonspecific leak causes free luminal Ca2 in secretory inter-
mediates to progressively decrease as they mature through
the intermediate compartment (Pezzati et al., 1997). Thus, the
ever-changing Ca2 signature of pre-Golgi intermediates
could be used in a manner not yet appreciated at other
transport steps. For example, the high luminal Ca2, and
thus Ca2 leak, from the ER and newly formed COPII ves-
icles would tend to discourage back-fusion of COPII vesicles
with the donor compartment, simultaneously favoring their
fusion with more mature, functional VTCs exhibiting lower
Ca2 signatures and discouraging premature fusion with
the Ca2-rich Golgi. This would enforce an ordered direc-
tionality to COPII vesicle fusions. On the other hand, should
an abundance of cargo dictate a dramatic increase in vesicle
budding beyond the acceptor capacity of pre-existing, ma-
ture VTCs, the primary vesicles’ prolonged dwell time near
ERES would eventually result in lower Ca2 signatures and
greater homotypic fusion of primary vesicles to generate
nascent VTCs. This homeostatic mechanism could thus en-
force efficient forward movement of cargo through pre-
existing secretory and sorting intermediates, yet also repre-
sent a means to dictate new VTC biogenesis when excessive
cargo loads dictate. By the time mature VTCs reach the Golgi
area, they may be nearly depleted of free luminal Ca2; yet,
Golgi Ca2 ATPases maintain high luminal Ca2 within
Golgi cisternae themselves. Hence, the documented require-
ment for Ca2 for fusion of pre-Golgi intermediates with the
Golgi (Beckers and Balch, 1989) and fusion within the Golgi
(Porat and Elazar, 2000) would direct the ordered fusion of
mature VTCs with an appropriate high Ca2 acceptor com-
partment. The differing responses to Ca2, suppressive (near
ER exit sites) versus stimulatory (near the Golgi), could be
dictated by differing accessory trafficking proteins, such as
ALG-2, that may be recruited to and lost from maturing
secretory intermediates in a stage-specific manner.
Depletion of luminal Ca2 caused dramatic changes in the
organization of the ER-Golgi intermediate compartment
(Figures 1 and 2), recruitment of trafficking machinery to
pre-Golgi intermediates (Figure 4), and rates of homotypic
COPII vesicle fusion (Figures 3, 5, and 6). These changes
may affect the efficiency of anterograde trafficking. We also
anticipate that the rearrangements caused by luminal Ca2
depletion should affect the efficiency of cargo sorting, an-
other primary function of VTCs. The overall morphology
and size of VTCs is probably a determining factor of both
their transport and sorting capacity. However, Ca2-depen-
dent residual coat retention could present a more direct
mechanism by which sorting capacity could be regulated.
The presence of Ca2-stabilized residual COPII coat on pre-
Golgi intermediates could create membrane microdomains
within which cargo from different vestigial vesicles remains
relatively restricted. This would potentially allow antero-
grade cargo to remain relatively concentrated in certain
regions of VTCs, forcing the other, noncoated, regions to
accumulate extra membrane and escaped ER proteins and
machinery for more efficient return to the ER. VTCs are
perhaps the most active sorting station of the secretory
pathway; indeed, the majority of membrane exported from
the ER in COPII vesicles seems to be retrieved during the
process of VTC maturation and cargo concentration (Mar-
tínez-Menárguez et al., 1999). Powerful new techniques that
combine high pressure freezing, three-dimensional electron
tomography, and immunolabeling have continued to sup-
port the finding that 70% of COPII labeling around ERES
is present on free vesicles and dumbbell-shaped tubules not
physically continuous with the ER (Zeuschner et al., 2006).
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This is strong evidence for residual COPII proteins remain-
ing on (or else rebinding to) membranes after budding,
tethering, and possibly even fusion. Unfortunately, our ex-
periments do not yet definitively indicate whether residual
COPII coat remains after homotypic vesicle fusion. Al-
though our experiments demonstrate the ability of BAPTA
to stimulate at a very late stage in the in vitro assay (Figure
6B, red line) and thus imply postfusion membrane mixing
effects of residual coat, the mechanism of BAPTA action is
not completely understood (see below) and our bulk immu-
noisolates of nascent VTCs do not unambiguously prove the
existence of sec31 on a fused structure, per se. On the other
hand, our experiments using ALG-2 at least prove that re-
sidual outer shell can remain long enough to regulate at a
prefusion stage. The functional impacts of residual COPII
coat during VTC biogenesis may occur at different stages in
tethering, docking, fusion, and even postfusion mechanisms.
The decreasing luminal Ca2 signature of maturing VTCs
has also been suggested to play a direct role on sorting via
the activity of cargo receptors such as ERGIC-53 (Appen-
zeller-Herzog et al., 2004).
The precise relationship between luminal Ca2 and the
mechanism of BAPTA action (Figures 3–6) remains some-
what speculative. The functional selectivity of BAPTA over
EGTA, and the partial reproduction of the effects of BAPTA
by EGTA/AM are consistent with leaking luminal Ca2,
very near the site of membrane fusion, as the functionally
relevant Ca2. The ability of BAPTA to aggressively neutral-
ize spatially restricted and fleeting Ca2 gradients has been
the conventional explanation for BAPTA’s selectivity in
many cell systems (see Burgoyne and Clague, 2003, and
references therein). However, we were unable to mimic
BAPTA using Ca2 ionophores such as A23187 or ionomy-
cin (data not shown), suggesting that the functionally rele-
vant Ca2 pool was resistant to these conditions. The rele-
vant Ca2 pool may persist in the presence of ionophores;
for example it may be tightly membrane associated in such
a manner that BAPTA, which contains aromatic rings that
could potentially interact with membranes (Figure 3C), is a
uniquely functional chelator. It is also possible that BAPTA
simply chelates free cytosolic Ca2 to lower equilibrium
levels than EGTA under biological conditions, despite their
apparently equal Ca2 affinities. That the effects of BAPTA
are related to Ca2 chelation is strongly supported by our
data: 1) excess Ca2 neutralizes the ability of BAPTA to
stimulate fusion (Figure 3B); 2) a structurally distinct hydro-
phobic chelator EGTA/AM, but not the hydrophilic EGTA,
can partially mimic the effect (Figure 3D); 3) BAPTA specif-
ically extracts coat components sec31 and -COP previously
shown to be stabilized by Ca2 on the membrane (Figure 4)
and the EF-hand protein ALG-2 causes opposite effects (Fig-
ures 4 and 5). That BAPTA stimulates our fusion assay
through a bona fide fusion mechanism is also clear, because
it causes very little increase in heterotrimers in the presence
of anti-syntaxin 5 antibody (Figure 5C). The precise relation-
ship between luminal Ca2 pools, ALG-2 and the function-
ally selective effects of chelators remain to be fully ex-
plained.
ALG-2 has been implicated in the Ca2-dependent stabi-
lization of sec31 at ERES, but no consequences of ALG-2 on
ERES function have yet to be demonstrated (Yamasaki et al.,
2006; la Cour et al., 2007; Shibata et al., 2007). It is interesting
to speculate that the lack of ALG-2 effects on vesicle budding
may have been because ALG-2’s most limiting function
occurs later in the pathway, during vesicle targeting and
fusion. Other ERES machinery may provide sufficient stabi-
lization of sec31 for budding purposes. Later, after GTP
hydrolysis by sar1 and in the absence of ERES scaffolding
proteins, ALG-2 may play a much more limiting role in
maintaining microdomains of COPII coat on vesicles for the
purpose of regulating fusion and/or sorting (Figures 5 and
6). However, the details of how ALG-2 may do this remain
sketchy. PEF proteins such as ALG-2 seem to exist either as
homodimers or heterodimers with another PEF protein
(Maki et al., 2002); for example, ALG-2 can exist as a ho-
modimer or as a heterodimer with the PEF protein peflin
(Kitaura et al., 2001; Okumura et al., 2009). The PEF homo- or
heterodimer may then cross-bridge two ligand molecules in
a Ca2-dependent manner. For example, ALG-2 mediates a
Ca2-dependent complex between alix and tsg101, two pro-
teins involved in multivesicular body biogenesis (Okumura
et al., 2009). Based upon this precedent, we might expect that
ALG-2 on pre-Golgi intermediates is cross-bridging sec31
either to itself or to another, more stably membrane associ-
ated binding partner. We do not know what this other
ALG-2 receptor on COPII-derived vesicles may be, although
a luminal Ca2 conducting protein would be a tantalizing
possibility that would fit with the chelator selectivity of our
effects. ALG-2 had a much greater impact on sec31 retention
than retention of sec23 (Figure 4, C and D). Our speculation
would be that the COPII inner shell is maintained on the
membrane primarily through interaction with vesicle cargo,
whereas the outer shell, sec31, requires Ca2-dependent
interactions with ALG-2 for stabilization. One commonality
of PEF proteins is their interaction with proline motifs of the
target proteins. Indeed, ALG-2 interacts with a proline-rich
region of sec31 (Yamasaki et al., 2006). Because sec23 also
interacts with the proline-rich domain of sec31 (Shaywitz et
al., 1997; Bi et al., 2007), it is even possible that ALG-2 binds
mutually exclusively with sec23—effectively forcing sec31
from an inner shell-, cargo-, and sar1-dependent membrane
association into an ALG-2– and Ca2-dependent mode of
association. One challenge in nailing down functions of the
PEF proteins is their potential redundancy. Whether other
members of the PEF family such as the closely related peflin
protein could in part compensate for ALG-2 depletion is not
known. Despite strong evidence for ALG-2 involvement in
diverse cellular functions, ALG-2 knockout animals have
had few visible defects. Indeed, we have so far observed no
dramatic rearrangements of VTCs or ERES upon 90%
ALG-2 knockdown in NRK cells (data not shown). Multiple
knockdowns and/or dominant-negative approaches may be
required to provide absolute proof of the significance of
ALG-2 to the COPII biosynthetic secretory pathway.
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